OrthoLogic buys Continuous Passive Motion (CPM) from Danninger:
This article was originally published in Clinica
For a total of $13 million, including the assumption of $4 million in debt, OrthoLogic has bought Danninger's Continuous Passive Motion business. The purchase is one of a string made by OrthoLogic in an attempt to position itself as the leading national supplier of CPM products, which are important in orthopaedics for bone healing.
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.
Anticipating a July approval of its cantharidin formulation, Verrica says it is poised to implement a buy-and-bill model for a clinician-administered product with an addressable market of 6 million.